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Abstract
Background: The response of the joint to anterior cruciate ligament (ACL) injury has not been fully characterized.
In particular, the characterization of both catabolic factors, including interleukin-6 (IL-6), interleukin-8 (IL-8), and
markers of ongoing tissue damage (CRP), and anabolic factors, including vascular endothelial growth factor (VEGF),
transforming growth factor β-induced (TGFβI), and the presence of CD163+ macrophages, have not been well defined.
In this study, we hypothesized ACL injury would catalyze both catabolic and anabolic processes and that these would
have different temporal profiles of expression.
Methods: Adolescent Yucatan minipigs were subjected to ACL transection. Within the joint, gene expression
levels of IL-6, IL-8, VEGF, and TGFβI were quantified in the synovium, ligament, and provisional scaffold located
b e t w e e nt h et o r nl i g a m e n te n d sa td a y s1 ,5 ,9 ,a n d1 4p o s t - i n j u r y .M a c r o p h a g ei n f i l t r a t i o nw a sa l s oa s s e s s e di n
the joint tissues over the two week period. Serum C-reactive protein (CRP) levels were measured at multiple
time points between 1 hour to 14 days after injury.
Results: Increases in IL-6 and IL-8 gene expression peaked at day 1 after injury in the synovium and ligament.
CRP levels were significantly increased at day 3 before returning to pre-injury levels. VEGF and TGFβIg e n ee x p r e s s i o n
did not significantly increase until day 9 in the synovium and were unchanged in the other tissues. CD163+ macrophages
increased in the ligament and synovium until day 9.
Conclusion: Taken together, these results suggest that the response within the joint is primarily catabolic in the first
three days after injury, switching to a more anabolic phase by nine days after injury. The effect of medications which alter
these processes may thus depend on the timing of administration after injury.
Keywords: ACL, Injury, Catabolic, Anabolic, Inflammation, Wound healing, Macrophage, CRP
Introduction
Injury and wound healing are complex processes. The
early days after injury are typically marked by an influx
of inflammatory cells, such as neutrophils, lymphocytes,
and monocytes. The inflammatory cascade is critical in
this initial phase of wound healing and facilitates wound
debridement and cell recruitment. There are both cata-
bolic and anabolic processes involved in this inflamma-
tory stage. Prolonged catabolism may lead to excessive
matrix degradation, while insufficient anabolic responses
may lead to a failure of the wound to heal [1]. Previous
work in a large animal has shown that a delay of as little
as two weeks between anterior cruciate ligament (ACL)
injury and enhanced primary repair negatively affects
the functional performance of the repaired tissue [2].
The response to injury which develops over time is not
yet fully understood, thus there is a need to understand
the source of this negative effect as most patients would
likely experience a delay between ACL injury and repair.
Prior studies have reported that after injury in liga-
ments located outside the joint, as in the medial collat-
eral ligament (MCL), an orderly progression of events
occurs [3]. There is an initial inflammatory phase which
typically lasts up to 5 days [4]. This is then followed by a
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jury [4]. In those extra-articular tissues, the switch from
catabolic to anabolic phase is thought to be mediated by
the earlier infiltration of macrophages, fibroblasts, and
endothelial cells, as deposited provisional extracellular
matrix is slowly remodeled [4]. However, while these
similar histologic phases have been seen for the ACL
after injury [5], it is less well-known how the changes
seen in the ligament might be also reflected in the other
tissues which may significantly affect the ligament re-
sponse, namely, synovium and provisional scaffold. We
hypothesized that inflammatory changes would be seen
not only in the transected ACL, but also in these other
important articular structures.
The ACL does not live in isolation; rather, it is in the
complex physiologic environment of the synovial fluid,
where multiple tissues are metabolically connected by
the synovial fluid. The synovial fluid is produced princi-
pally by the synovium [6] and bathes the ACL itself, as
well as the wound site after ACL transection. To date,
the majority of studies evaluating the inflammatory re-
sponse after ligament injury have studied the ligament
or explants of the ligament in isolation [7,8]. For the first
time, we are able to look at the simultaneous inflamma-
tory response in both the ligament and the synovium
lining the injured joint, both of which have the potential
to influence the ligament response after injury. In addition,
the blood clot which forms in the joint after injury is an-
other possible source of inflammatory factors, given the
relatively high number of leukocytes typically found in that
structure in the first days after injury [9]. We have selected
synovium, ligament, and this provisional scaffold for exam-
ination in this study, as these three tissues in the intact
knee are likely to influence the inflammatory response
within the knee joint after ACL injury.
In wound healing, the immediate post-injury phase is
marked by an early increase in catabolic markers, in-
cluding C-reactive protein (CRP), interleukin-6 (IL-6)
and interleukin-8 (IL-8), which are typically seen within
the first few hours to days after an insult or injury [10].
Wound healing then shifts to anabolic functions, with a
shift to the reparative, or M2 macrophage phenotype
(CD163+), and production of factors that stimulate pro-
duction of extracellular matrix and revascularization,
such as transforming growth factor beta (TGF-β) and
vascular endothelial growth factor (VEGF) [11,12]. Re-
cently, there has been interest in stopping or preventing
the catabolic response after ACL injury in an effort to
slow the early and irreversible loss of cartilage proteins
seen after ACL injury [13-15]. However, the optimal
timing of this intervention is unknown. We therefore
wished to determine when the switch from primarily
catabolic to anabolic inflammatory cytokines occurs
after ACL injury.
A wide variety of proteins have been identified as
markers of early inflammation and wound healing re-
sponse. IL-6 and IL-8 are pro-inflammatory cytokines
which have been shown to be produced during the first
48 hours after an injury, increasing more than 10-fold
and 20-fold, respectively, then decreasing over the next
2 weeks in male subjects with an ACL tear [16]. IL-6
and IL-8 are considered important mediators of the
acute inflammatory phase of wound healing, appearing
in the joint immediately following ACL injury and per-
sisting for approximately 1 week [17]. IL-8 is also con-
sidered a main chemoattractant for neutrophils to the
wound site, with slow clearance and long-lasting chemo-
attractant properties in the wound environment [18].
CRP levels are often used as a measure of tissue damage,
and elevated levels are observed in patients with ongoing
cartilage loss associated with arthritis [19,20]. Knowledge
of these early markers of inflammation following ACL
injury is of interest in both human patients and animal
pathology models, in order to identify new treatment
methods and their effects.
In addition to catabolic cytokines, tissue injury stimu-
lates expression of several anabolic factors. Members of
the TGF-β superfamily have been found to be key ana-
bolic factors, stimulating collagen production [21] and
regulating wound healing, cellular proliferation and differ-
entiation, and angiogenesis [22]. TGFβ-induced (TGFβI)
has been detected in various embryonic tissues of the knee
during development, including cartilage, meniscal and
ligamentous tissues [23]. A lack of TGF-β signaling in the
mouse has been shown to negatively affect knee develop-
ment, resulting in a lack of menisci and cruciate ligaments
critical to knee function [23]. VEGF is a known stimulator
of angiogenesis and revascularization of tissues [24,25],
and expression in the inflammatory phase may contribute
to cell migration and proliferation [26]. Increased VEGF
expression within the wound site has been correlated with
vascular ingrowth, providing a source of nutrients, growth
factors and cells to the injured area [25,27]. The timing
and source of these markers following ACL injury is of
interest for future development of therapeutic strategies.
Macrophages also play a central role in wound healing,
accumulating at the site of injury and performing a wide
variety of tasks, ranging from phagocytosis of debris to
scar tissue formation and regulation of angiogenesis
[28]. Recent work has attempted to identify and classify
macrophages along a spectrum determined by their
means of activation, as well as their function. CD68 is
highly expressed by monocytes and macrophages and is
commonly used to indicate undifferentiated macrophages
[29,30]. After a period of time within the wound, macro-
phages, in particular, change to an alternatively activated,
anabolic phenotype (CD163+ or M2). CD163+ macro-
phages release anabolic cytokines and secrete extracellular
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role in the wound healing response [28,29].
In this study, we hypothesized that ACL injury would
result in an increase in early catabolic markers, particu-
larly CRP, IL-6, and IL-8, in the first few days after in-
jury. We also hypothesized than an increase in anabolic
markers of the proliferative phase would be observed
later in the two week period.
Materials and methods
Thirty adolescent Yucatan minipigs (Coyote CCI, Douglas,
MA), aged 12–15 months, were obtained for use in this
study. All minipigs were handled according to approved
IACUC protocols at Animal Resources at Children’sH o s p i t a l
(ARCH, Boston, MA). Twenty-four minipigs were subjected
to ACL transection, followed by tissue harvest at 1, 5, 9, or
14 days post-injury. A group of 6 Yucatans was used to
provide unoperated control specimens.
Surgical procedure
Unilateral ACL transection was performed as previously
described [31,32]. Briefly, the ACL was exposed by per-
forming a medial arthrotomy and partial resection of the
fat pad. The ACL was cut using a scalpel blade at the
junction of the proximal and middle thirds, functional loss
of the ACL verified, and the knee closed in layers. Minipigs
were allowed normal nutrition and ad lib activity following
surgery throughout the experimental period.
Tissue collection
The ACL, including any provisional scaffold matrix
found on the end of the injured ligament, and medial
synovium from each minipig were harvested after the
specified time points from the injured knee of each sub-
ject (day 1, 5, 9, or 14, n=6 for each time point) as previ-
ously described [32]. Each tissue specimen was submerged
in a cryovial containing RNALater (Ambion, Austin, TX,
USA), flash frozen in liquid nitrogen, then stored at −80°C
until analyses. A portion of the ligament tissue was also
embedded within OCT medium (Sakura Finetek, CA,
USA), frozen, and stored at −80°C for histological analysis.
Synovium and intact ACL tissue were also harvested from
six control subjects. Systemic blood of control minipigs
was clotted to serve as a provisional scaffold control for
the intact ACL group.
The animals belonging to the groups sacrificed at day
9 and 14 were also subjected to serum draws at alternat-
ing time points. IACUC protocols demanded a break be-
tween anesthesia events. Therefore, one group was sampled
pre-transection, then 1 h, 5 days, 12 days, and 14 days post-
injury, while a second group was sampled at 3 h, 1 day,
3 days, 7 days and 9 days post-injury. Blood was collected
in serum separator tubes, clotted at room temperature,
centrifuged at 1000X g for 10 min, and the serum ali-
quoted in 500 μL aliquots and stored at −80°C.
C-reactive protein
CRP concentrations in serum aliquots were quantified via
the Pig C-Reactive Protein ELISA Test Kit (Life Diagnostics,
Inc., West Chester, PA) according to the manufacturer’s
protocol.
qPCR and data analysis
The ligament, synovium, and provisional scaffold were
examined for mRNA expression of several genes using
real-time reverse transcriptase polymerase chain reaction
(qPCR) run in duplicate as previously described [32]. Briefly,
total RNA was extracted from frozen tissue, treated with
DNAse I, quantified, and reverse transcribed to generate
cDNA. Primers are summarized in Table 1. Sybr Green PCR
Mastermix (Applied Biosystems, Foster City, CA, USA),
water, forward and reverse primer, and 10 ng cDNA were
mixed and quantified in a reaction volume of 10 μl. No tem-
plate controls were included to indicate contaminants
or non-specific amplification and an Applied Biosystems
7900HT (Applied Biosystems) was used for amplification
and detection. Level of gene expression was normalized to
the housekeeping gene, GAPDH. Relative gene expression
was calculated using the 2
-ΔCt method [33].
Macrophage histology
Ligament, synovium and provisional scaffold tissue spec-
imens were sectioned (6 μm) and individually stained
with CD163 (MCA2311, AbD Serotec, Raleigh, NC)
and counterstained with hematoxylin (Mass Histology
Service, Inc., Worcester, MA). No pre-treatment was
required, and tissue sections were incubated in the primary
antibody at a 1:250 dilution overnight at 4°C. The sections
were then incubated for 45 min in the secondary antibody
(Vector mouse ImmPRESS kit, Vector Laboratories,
Burlingame, CA) followed by custom labeling with
DAB for 1 minute.
Table 1 Sequences of porcine-specific qPCR primers
Gene Forward primer Reverse primer
GAPDH [34] GGG CAT GAA CCA
TGA GAA GT
GTC TTC TGG GTG GCA
GTG AT
IL-6 [35] TGG GTT CAA TCA
GGA GAC CT
CAG CCT CGA CAT TTC
CCT TA
IL-8 [35] GAA GAG AAC TGA
GAA GCA ACA ACA
TTG TGT TGG CAT CTT
TAC TGA GA
VEGF ATC TTC AAG CCG
TCC TGT GT
TGC ATT CAC ATT TGT
TGT GC
TGFβI[ 23] ATC GGA ATA GCC
TGT GCA TC
CCT GGA AGG CTT CAT
TGG TA
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The time course of serum CRP levels was described using
repeated-measures analysis of variance with an autore-
gressive covariance structure (PROC MIXED, SAS version
9.3, SAS Institute, Cary, NC). Gene expression was sum-
marized as gene expression per cell, mean and standard
deviation. Overall differences in gene expression levels
(both across time for a particular gene and within each
tissue) were assessed using a two-factor ANOVA followed
by post-hoc Bonferroni-Dunn testing and one-way ANOVA
to assess the effect of time on the gene expression in the in-
dividual tissues. P <0.05 was considered statistically signifi-
cant for all analyses. Statistical analyses were performed
using SAS (version 9.2, SAS Institute Inc., Cary, NC) and
Statview (version 5.0.1, SAS Institute Inc.).
Results
Catabolic factors
C-reactive protein
Serum CRP levels increased following ACL injury (Figure 1),
with a significant increase (5-fold) over baseline observed
at day 1 (P < 0.0001). CRP levels continued to rise and
were significantly elevated (6-fold) over baseline at day
3 (P < 0.0001), then slowly returned to normal levels
over the remainder of the two week period though sig-
nificant increases over baseline were still observed at
days 5 and 7 (P = 0.0361 and 0.0133, respectively).
IL-6 gene expression
Expression of IL-6 was significantly higher in the syno-
vium when compared to the ligament and provisional
scaffold (P<0.01 for both comparisons) and peaked at
day 1 after injury (P <0.0001) where the levels of IL-6
gene expression in the synovium had increased by 20X
over baseline (P <0.001) (Figure 2A). The ligament had a
12-fold increase in IL-6 gene expression from day 0
to day 1 (P< 0.003) (Figure 2B) and the scaffold had a
46-fold increase in expression from day 0 to day 1 (P< 0.02,
not significant) (Figure 2C). After the peak at day 1, levels in
all tissues had significantly decreased by day 9 (P< 0.0001).
IL-8 gene expression
IL-8 gene expression levels were significantly higher in
the provisional scaffold when compared to the ligament
and synovium (P <0.0001 for both comparisons) and peaked
at day 1 for all tissues (P <0.0001). There the levels of ex-
pression were 10X higher in the provisional scaffold
than in the synovium (Figure 2C). The provisional
scaffold had a 16-fold increase in expression from day
0 to day 1 (P< 0.0001), while the ligament had a 44- fold in-
crease in expression from day zero (P< 0.0025) (Figure 2B)
a n dt h es y n o v i u mh a da n8 - f o l di n c r e a s ei ne x p r e s s i o nf r o m
day zero to day 1 (P <0.001) (Figure 2A). Levels in all tissues
had significantly decreased by day 9 (P< 0.0001).
Anabolic factors
VEGF gene expression
A significant increase in VEGF gene expression from base-
line levels was noted in the synovium at day 9 (P< 0.0001).
VEGF gene expression levels were significantly higher
in the provisional scaffold when compared to the liga-
ment (P<0.008), but not significantly different from the
synovium (P< 0.04). On average, the gene expression
levels of VEGF were 2.5X higher in the provisional
scaffold than in the ligament (Figure 2).
TGFβI gene expression
TGFβI expression levels significantly increased in all tissues
over the course of the experiment (Figure 2, P<0.0001 for
all comparisons between day 0 and days 9 and 14, as well
as between day 1 and days 9 and 14). TGFβIg e n ee x p r e s -
sion levels were significantly higher in the synovium
when compared to the ligament and provisional scaffold
(P<0.001 for both comparisons) and were higher in the
ligament than in the provisional scaffold (P<0.0008).
Figure 1 CRP concentrations in serum collected pre- and post-injury. Data represent mean concentration±SEM. Asterisks indicate significance
determined at P<0.05 compared to baseline (Day 0) concentrations.
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In the intact ligament, very few CD163+ cells were seen
(Figure 3B). Following ACL injury, CD163+ cells increased
in number within the ligament, as well as within the syno-
vium and provisional scaffold. The highest concentrations
of CD163+ cells were observed at days 9 (Figure 3I, J, and
K) and 14 in the synovium, ligament, and provisional scaf-
fold (Figure 3L, M, and N).
Discussion
In the ACL injury model, even without direct injury to
the synovium in the areas evaluated, an initial catabolic
Figure 2 Mean gene expression relative to GAPDH of IL-6, IL-8, VEGF, and TGFβI in the (A) synovium, (B) ligament, and (C) provisional
scaffold following ACL injury. Note the log 10 scale on the y-axis. Error bars represent standard error of the mean and asterisks indicate significance
determined at P<0.05 within tissue type compared to baseline (Day 0) levels.
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Specifically, IL-6 and IL-8 were significantly upregulated
at day 1, returning toward normal levels by day 5. This
was reflected in the systemic blood, as well with an in-
crease in CRP levels in the plasma peaking at day 3. Taken
together, these changes suggest that an ACL transection
results in an immediate coordinated catabolic response by
the synovium as well as the ligament. While there were no
significant indicators of anabolic function in the ligament
tissue, the synovium had significant increases in the gene
expression of both VEGF (day 9) and TGFβI( d a y s9
and 14) later in the time course, suggesting that while
ap r o d u c t i v er e s p o n s et oi n j u r ym a yb eo c c u r r i n gi n
the synovium, it is less clear this occurs in the trans-
ected, intra-articular ACL. This would be consistent
with prior reports of the failure of the transected ACL
to mount an effective healing response [5,36].
Following ACL transection, CRP levels peaked at 3
days following injury, exhibiting a strong correlation to
human patients undergoing ACL reconstruction, where
mean CRP levels increased significantly the first post-
operative day, peaked on day 3, and returned to baseline
levels by day 15 [37]. Similar results were also observed
in the plasma of human patients undergoing ACL recon-
struction, with significantly increased plasma CRP levels
noted 3 days after the operation, which returned to pre-
operative levels by 2 weeks post-surgery [38]. In addition,
these data suggest the porcine model has a similar CRP
response to the human knee, and therefore may be a rea-
sonable surrogate for studying human joint injury.
Figure 3 Light microscopy images of CD163 antibody stained histological sections obtained from the synovium (A, C, F, I, L), ligament
(B, D, G, J, M), and provisional scaffold (E, H, K, N) at days 0 (A,B), 1 (C, D, E), 5 (F, G, H), 9 (I, J, K), and 14 (L, M, N) following ACL injury.
Scale bar represents 50 μm.
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switch from catabolic to anabolic processes within the
joint after ACL transection. Here, IL-6 and IL-8 gene ex-
pression levels were both seen to peak at day one in
both the ligament and synovium before declining, which
is consistent with reports of human synovial fluid levels
following ACL injury [17]. IL-8 in particular is released
by neutrophils in the wound site. These cells undergo
apoptosis within 1 to 3 days, and engulfment of the apop-
totic neutrophils can change the wound macrophages from
a catabolic phenotype to an anabolic phenotype (CD163+),
where they release VEGF [39]. Indeed in this study, we see
an increase in VEGF expression within the synovial tissue
at day 9, as well as an increase in CD163+ macrophages,
particularly within the wounded ligament at this same time
point. Thus, the IL-8/neutrophil/macrophage axis may be
particularly relevant in this injury model.
These results correlate with similar studies of synovial
fluid human patients where a peak in IL-6 levels was ob-
served within 24 hours after ACL injury and an increase
in IL-8 levels was apparent within 3 days of injury before
declining [17]. Interestingly, persistent presence of higher
levels of IL-6 in the synovial fluid was correlated with
painful ACL injuries; non-painful knees did not have ele-
vated levels of IL-6 [40]. Increased interferon gamma and
macrophage inflammatory protein beta concentrations
were also observed in the synovial fluid of these injured
patients [40]. Another study in humans with ACL tears
similarly observed elevated IL-6 and IL-8 levels in the syn-
ovial fluid initially, which decreased in concentration rap-
idly within 3 days of injury [17]. A similar peak was also
seen in tumor necrosis factor alpha (TNF-α), IL-1β,a n d
interleukin-1 receptor antagonist (IL-1RA) concentrations
in these patients, however, TNF-α levels remained rela-
tively high through 2 weeks and IL-1β and IL-1RA were
high until 6 days after injury [17].
Previous work by Nakahara et al. indicated that IL-6
induces VEGF production in human synovial fibroblasts
[41]. In this study, IL-6 gene expression levels peaked at
day 1, followed by a significant increase in VEGF gene
expression levels at day 9 in the synovium. VEGF con-
centrations in the drain fluid of patients undergoing
ACL reconstruction were also found to significantly in-
crease with time from surgery [42]. In studies of recon-
structed ACL graft tissue, the highest vascularity was
observed between 6–12 weeks [43,44]. In transected ACLs
treated with a suture repair plus a collagen-platelet com-
posite sponge, blood vessel concentration at the insertion
site was greatly increased at both 2 and 4 weeks in the ado-
lescent injury model [45]. Thus, the initial inflammatory
response may elicit VEGF gene expression and result in in-
creased angiogenesis within the native ligament tissue.
This study focuses on changes within the first two weeks
of ACL injury, though other studies have evaluated the
changes in gene expression in joint tissues at longer time
points [46,47]. Naraoka et al. found increased IL-6 gene
expression within the first three weeks after injury in hu-
man ACL tissue, as well as an increase in Collagen I gene
expression in the 3–8 week timeframe [47]. Additionally,
in a 6 week study in rabbits, Attia et al. noted increased
MMP-13 gene expression in the ligament at 1 week, with
increased Collagen I and III gene expression at the 6 week
time point [46]. However, these studies often evaluated a
single tissue rather than three joint tissues, the ligament,
synovium, and provisional scaffold, simultaneously. Future
studies to evaluate the simultaneous joint changes at lon-
ger time points are planned.
TGFβI expression was found to increase in all joint
tissues after ACL injury, with a peak increase seen at 9
days after injury. In prior studies, mRNA levels of TGFβI
have been shown to increase following macrophage en-
gulfment of apoptotic cells [48]. Dose and time effects of
TGFβI treatment were also shown to regulate collagen
levels in cultured fibroblasts, suggesting regulation may
occur through excretion of soluble factors by the macro-
phages [48]. These results suggest that TGFβI may act
as a mediator of the pro-fibrotic effects exhibited by
macrophages following ingestion of apoptotic cells [48].
Previous analyses from ACL injured and normal patients
have also shown a significant increase in both type I and
type III collagen gene expression in injured patients
compared to normal expression in the ligament [49].
Furthermore, in a study of patients undergoing ACL re-
construction, TGF-β and platelet-derived growth factor
(PDGF), which promotes cell migration and plays a sig-
nificant role in angiogenesis, were found to rapidly in-
crease in protein concentration in the drain fluid within
6 hours of surgery [42]. These increases in anabolic pro-
teins indicate there is a potential to mount a scarring re-
sponse followed by healing after ACL injury, however,
the resulting non-functional scar may be due to the early
increase in catabolic proteins.
The presence of CD163+ macrophages was found to
increase after injury, plateauing at day 9. In other wound
healing models, macrophages have been found to mi-
grate from the peripheral blood toward a gradient of
chemoattractants, eventually accumulating at the wound
site. The CD163+ macrophages have previously been as-
sociated with anabolic wound healing activities, including
stimulating increased collagen production in fibroblasts
following ingestion of apoptotic debris [29,48]. The
CD163+ phenotype has been described as the hallmark
of the wound healing macrophage, dampening the effects
of oxidative injury from hemolysis during bruising or tis-
sue injury, and transitioning into this “resolving macro-
phage” phenotype with increasing time from injury- even
in less traumatic skin blistering models [50]. Thus, their
presence in the later phase of the response to ACL injury
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bolic processes in the joint.
The early biological changes which occur following
ACL injury are believed to play an important role in
subsequent joint health. In addition to the ligament’s
limited capacity to heal without surgical intervention,
which largely serves to impart mechanical stability to
the injured joint, post-traumatic osteoarthritis has been
shown to develop within 10–20 years in more than 50%
of individuals who experience an ACL tear [51]. Loss of
proteoglycan and collagen molecules from cartilage has
been shown within the first few weeks after injury
[52,53]. Neuman et al. observed evidence of reduced
glycosaminoglycan content in cartilage from patients
examined at 3 weeks and 2.3 years after ACL injury
[ 5 4 ] .W eh a v es i m i l a r l ys h o w na ni n c r e a s eo ft y p eI I
collagen fragments in synovial fluid, which nearly doubled
within 5 days of ACL injury [32]. Thus, knowledge of, and
intervention in, the catabolic pathways initiated by ACL
rupture may help prevent further damage to both the liga-
ment and cartilaginous structures after injury.
A few study limitations should be noted. Most import-
antly, an animal model was required to allow for tissue
harvest at various time points after injury. Thus, it is
possible that the timing of CRP production, cytokine
gene expression, and macrophage infiltration may be dif-
ferent in humans; however, the CRP [37] and IL-6 [17]
profiles reported here closely matches that previously re-
ported for humans with ACL injury. The porcine model
was chosen in part due to its size, ACL dependency, and
gait similarity to humans [55-58]. There is extensively
conserved homology between the porcine genome and
the human genome, far more than between human and
mouse or other rodents [59]. The pig is therefore an im-
portant model for human health, particularly for under-
standing complex traits such as wound healing, obesity,
and cardiovascular disease [60-62]. In addition, the por-
cine knee is approximately the same size as the knee of
a small human, thus diseases which may be dependent
on tissue size are more easily modeled in this organism,
as has already been shown for retinitis and diabetes
[63,64]. This model has been used to study ACL injury
and surgical and tissue engineering approaches for heal-
ing, thus allowing for comparisons and further insight
into the biological mechanisms following injury [65-67].
The minipig also serves as a model for other human condi-
tions, including testing of diabetes drugs and mechanical
heart valves, and even serves as a source of donor tissue for
prosthetic aortic valves [68-70]. Additionally, mRNA ex-
pression is reported here, however, expression levels may
not directly correlate with protein release. Another limita-
tion was the control tissue specimens were obtained from a
separate group of animals as altered gait due to ACL injury
could potentially affect the tissues of the contralateral knee.
Conclusions
ACL injury, similar to other wound responses, has both
a catabolic and anabolic response. In this study, we re-
port that while the catabolic factors evaluated in this
study are active primarily in the first three days after in-
jury, the anabolic factors studied here become more
prominent at a week or more from injury. Future studies
aim to regulate these processes, with the goal of minim-
izing the catabolic phase of tissue destruction and accel-
erating the anabolic phase of tissue repair.
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